CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 162 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $900 | -8.0% | 32,697 | +13.5% | 0.01% | 0.0% |
| Q2 2023 | $978 | +19.6% | 28,813 | +26.8% | 0.01% | +12.5% |
| Q1 2023 | $818 | -19.2% | 22,723 | 0.0% | 0.01% | -27.3% |
| Q4 2022 | $1,013 | -99.9% | 22,723 | -22.4% | 0.01% | +10.0% |
| Q3 2022 | $823,000 | -25.0% | 29,276 | -9.2% | 0.01% | -9.1% |
| Q1 2022 | $1,098,000 | +27.1% | 32,242 | +44.1% | 0.01% | +37.5% |
| Q4 2021 | $864,000 | -28.5% | 22,371 | 0.0% | 0.01% | -27.3% |
| Q3 2021 | $1,208,000 | +35.6% | 22,371 | -16.0% | 0.01% | +37.5% |
| Q2 2021 | $891,000 | – | 26,631 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
| Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
| COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
| Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
| VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
| TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
| RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
| Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
| Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
| Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |